• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Increased risk of thyroid nodules with bomb radiation exposure in childhood

byJames JiangandMarc Succi, MD
December 31, 2014
in Chronic Disease, Endocrinology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a cohort of patients who were younger than 10 years of age at the time of radiation exposure at Hiroshima or Nagasaki, there was a significantly increased risk of malignant and benign thyroid nodules more than 10 mm in diameter.

2. There was a significant association between prevalence of thyroid nodules and the age at exposure, as well as radiation dose, suggesting dose effects were higher for earlier childhood exposure.

Evidence Rating Level: 2 (Good)

Study Rundown: Thyroid cancer has been associated with ionizing radiation exposure in early childhood. In a prospective study of survivors of the Chernobyl nuclear reactor incident, exposed survivors had a higher risk of thyroid cancer. Although previous studies have examined the use of thyroid ultrasound in detecting nodules in radiation-exposed populations, there has been little investigation into the dose response. This study aimed to investigate thyroid disease in atomic bomb radiation exposed patients from Hiroshima and Nagasaki, 62 to 66 years after exposure, as well as to investigate radiation dose-response relationships in this population.

The study authors found a significant risk association with atomic bomb radiation exposure and malignant and benign nodules more than 10 mm in diameter. There was a significant association between prevalence of thyroid nodules and the age at exposure as well as radiation dose, suggesting dose effects were higher for earlier childhood exposure. There was no dose response relationship found for thyroid nodules small nodules (< 10 mm in diameter). One limitation of the study is the retrospective nature of the study. Strengths include the large number of patients included, as well as the availability of dosimetry estimation of thyroid radiation dose exposure.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

Relevant Reading: Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident

In-Depth [retrospective cohort]: This study included 3087 Hiroshima and Nagasaki bomb survivors who were younger than 10 years at the time of exposure, who also participated in the thyroid study of the Adult Health Study. 2688 participants with known atomic bomb thyroid radiation doses were analyzed from October 2007 to 2011. All participants had thyroid ultrasound, and those with nodules more than 10 mm in diameter were referred to have fine-needle aspiration biopsy and cytology. The primary outcome was the prevalence of all thyroid nodules with 10 mm or more diameter, including solid nodules and cysts, prevalence of small thyroid nodules less than 10 mm in diameter detected by ultrasound.

470 patients had thyroid nodules of diameter 10 mm or more (17.6%). 16% of survey participants had solid nodules, with 1.8% with malignant tumors, and 7% with benign nodules, and 1.8% with cysts. The excess odds ratio per gray unit was 1.65 (95% CI 0.89-2.64) for all nodules, 4.40 (95% CI 1.75-9.97) for malignant tumors, and 2.07 (95% CI 1.16-3.39) for benign tumors. The age at exposure and the dose was significantly associated with prevalence of all nodules (P=0.003) and solid nodules (P<0.001). There was not a significant dose-response relationship for nodules less than 10 mm.

More from this author: Gloves after hand washing linked with fewer NICU infections, Ezetimibe (Zetia, Vytorin) use declining after ENHANCE trial publication in 2008

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: irradiationthyroid cancer
Previous Post

The Women’s Health Initiative: Risks outweigh benefits of combination hormone replacement therapy [Classics Series]

Next Post

Amyloidogenic genetic variant not associated with increased mortality in blacks

RelatedReports

Selpercatinib may provide an effective response against RET-mutated thyroid cancer
Chronic Disease

Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy

July 31, 2025
#VisualAbstract: Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
StudyGraphics

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

November 24, 2023
Patient Basics: Thyroid Cancer
Chronic Disease

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

October 19, 2022
Oncology

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

September 26, 2022
Next Post
Amyloidogenic genetic variant not associated with increased mortality in blacks

Amyloidogenic genetic variant not associated with increased mortality in blacks

Classics Series, Landmark Trials in Medicine

Letrozole superior to clomid for ovulation induction in PCOS [Classics Series]

Classics Series, Landmark Trials in Medicine

Vena caval filters in pulmonary embolism prophylaxis [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study
  • Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial
  • A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults: A Randomized Clinical Trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.